Marsh (NYSE:MRSH – Get Free Report) had its target price raised by equities researchers at Morgan Stanley from $190.00 to $195.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s price objective indicates a potential upside of 3.61% from the company’s current price.
Separately, Wells Fargo & Company boosted their price target on shares of Marsh from $199.00 to $203.00 and gave the stock an “equal weight” rating in a research note on Friday. Four investment analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $199.33.
Check Out Our Latest Analysis on MRSH
Marsh Stock Up 0.2%
Marsh (NYSE:MRSH – Get Free Report) last issued its quarterly earnings data on Thursday, January 29th. The company reported $2.12 EPS for the quarter, topping the consensus estimate of $1.97 by $0.15. The company had revenue of $6.60 billion during the quarter, compared to analyst estimates of $6.52 billion. Marsh had a return on equity of 31.60% and a net margin of 15.42%.Marsh’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.87 earnings per share.
Key Stories Impacting Marsh
Here are the key news stories impacting Marsh this week:
- Positive Sentiment: Q4 earnings beat and consulting-unit strength — Marsh reported $2.12 EPS vs. $1.97 est., revenue around $6.6B (beats estimates) and y/y revenue growth of ~8.7%; company commentary highlighted strength in consulting and insurance lines. Article Title
- Positive Sentiment: Fourth-quarter profit rise driven by core insurance business — coverage reiterates that insurance operations and fee-based consulting lifted profitability and revenue. This is the primary fundamental driver for the stock move. Article Title
- Positive Sentiment: Wells Fargo raised its price target to $203 (from $199) with an Equal Weight rating — the lift to a $203 target (~7.9% above current levels) likely contributed to buying interest. Article Title
- Positive Sentiment: Morgan Stanley nudged its target to $195 (from $190) and kept an Equal Weight rating — another upward revision that supports the stock. Article Title
- Neutral Sentiment: RBC reaffirmed a Sector Perform rating with a $200 target — a modestly constructive take but not a buy/upgrade; this is neutral-to-slightly supportive. Article Title
- Neutral Sentiment: Non-financial article (filming locations for “Under Salt Marsh”) is unrelated to Marsh plc’s business and unlikely to affect the stock. Article Title
About Marsh
Marsh is a global insurance broker and risk advisor that helps organizations assess, manage and transfer a broad range of risks. The firm provides insurance placement and broking services for commercial and public-sector clients as well as specialty solutions for families and high-net-worth individuals. Its work focuses on identifying exposures, designing risk-transfer strategies and securing coverage from insurers and reinsurers to protect clients’ assets and operations.
Services offered by Marsh include commercial property and casualty broking, cyber and professional-liability placement, employee benefits consulting, and industry-specific specialty lines such as marine, energy and construction.
Recommended Stories
- Five stocks we like better than Marsh
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Deutsche Bank Just Raised Their Gold Target to $6,000
Receive News & Ratings for Marsh Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh and related companies with MarketBeat.com's FREE daily email newsletter.
